Food and Drug Administration Commissioner Marty Makary said in September he was changing leucovorin’s label because it could help “hundreds of thousands” of children with the neurological condition.
Source link
FDA backs away from RFK Jr.’s claims about drug’s promise for autism patients
Online Chhattisgarh
Online Chhattisgarh, the premier platform for government news in Chhattisgarh, delivers accurate and transparent coverage from local to state levels. Our dedicated team ensures timely updates on policies, initiatives, and reforms, fostering informed citizenship. Committed to journalistic integrity, we promote transparency, accountability, and civic engagement for a thriving democracy
Leave a Reply